The process of developing the green paper promised by Government has just begun with a consultation meeting involving a range of health charities, including ARMA. It seems clear that MSK conditions will be included, but ARMA, with our members, will work with the Department to help shape what that looks like in the final Green Paper.
The Green Paper was promised when the government published Prevention is Better than Cure last November. The goal remains to improve healthy life expectancy by at least 5 extra years, by 2035, and to close the gap between the richest and poorest.…
Read more of this article
Since the NHS Long Term Plan (LTP) was published on 7 January 2019, the Universal Personalised Care: Implementing the Comprehensive Model has been published.
ARMA has welcomed the inclusion of references to MSK in the NHS Long Term Plan. The real challenge is how to implement this in the local NHS plans. ARMA has set out the “
The 7th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD) will take place October 17-19, 2019 in Taipei, Taiwan.
by Leyla Hannbeck, Director of Pharmacy at NPA
Pain Alliance Europe launched a new survey on stigma and chronic pain. One of the main “fights” PAE is leading is for the pain patient to be heard, believed and understood. The most recent survey developed deals with stigma related to chronic pain and will be open until the 1st of March, 2019.
FOREUM – Foundation for Research in Rheumatology – announces a programme to support innovative concepts to improve the diagnosis and treatment of Rheumatic Musculoskeletal Diseases (RMDs). This programme is designed as an open research call seeking for the best and most visionary approaches to better understand RMDs and to improve the life of patients with RMDs.